SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
193
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Glencore plc of Class Action Lawsuit and Upcoming Deadline – GLNCY

NEW YORK, Aug. 04, 2018 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Glencore plc (“Glencore” or the “Company”) (OTC MKT:  GLNCY) and certain of its officers.   The class action, filed in United States District Court, Southern District of New York, and docketed under index 18-cv-06286, is on behalf of a class consisting of investors who purchased or otherwise acquired publicly traded Glencore securities from September 30, 2016, and July 2, 2018, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

If you are a shareholder who purchased Glencore securities from September 30, 2016, to July 2, 2018, you have until September 7, 2018, to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com .   To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

[Click here to join this class action]

Glencore engages in the production, refinement, processing, storage, transport and marketing of metals and minerals, energy products, and agricultural products worldwide.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Glencore’s conduct would foreseeably subject it to heightened scrutiny by U.S. and foreign government bodies with respect to the Company’s compliance with money laundering and bribery laws and the U.S. Foreign Corrupt Practices Act (“FCPA”); and (ii) as a result, Defendants’ statements about Glencore’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.

On May 18, 2018, Bloomberg reported that the U.K.’s Serious Fraud Office was preparing to open a formal bribery investigation into Glencore.

On this news, shares of GLNCY fell $0.55 per share, or over 5%, to close at $10.13 per share on May 18, 2018, while shares of GLCNF fell $0.32 per share, or nearly 6%, to close at $5.06 per share on May 18, 2018.

Then, on July 3, 2018, pre-market, Glencore disclosed that the U.S. Department of Justice had issued its subsidiary Glencore Ltd a subpoena to produce documents and other records in connection with its compliance with U.S. money laundering statutes and the FCPA.

On this news, shares of GLNCY fell $0.86 per share, or over 9%, to close at $8.31 per share on July 3, 2018, while shares of GLCNF fell $0.41 per share, or nearly 9%, to close at $4.20 per share on July 3, 2018.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT: Robert S. Willoughby Pomerantz LLP rswilloughby@pomlaw.com 888-476-6529 Ext. 9980

Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 3

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 4

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 5

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 4

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights Into December's Top Mobile and CTV Apps for Revenue

Updated Category News Views 170

Top Revenue Generating Mobile and CTV Apps for December 2024 The evolving landscape of mobile and Connected TV (CTV) applications continually captivates users and advertisers alike. As 2024 comes to a close, the spotlight shines on the highest-grossing apps in North America, specifically in the United States and Canada, revealing significant trends in user engagement and...

Continue Reading
LET Mining's Cloud Strategy for XRP: Earn Passive Income Today

Updated Category News Views 106

Introduction to LET Mining's New Approach LET Mining is making waves with its innovative strategy that leverages XRP for cloud mining. This fresh perspective has caught the attention of numerous XRP holders, sparking excitement about its long-term profit potential. As more users join the platform, LET Mining is focusing on refining its computing power allocation to...

Continue Reading
Understanding Recent Changes in American Intl Gr's Short Interest

Updated Category News Views 70

Understanding American Intl Gr's Short Interest Dynamics American Intl Gr (AIG) has recently seen a notable change in its short percent of float, which has decreased by 3.24% since the last report. This change reflects a current total of 10.23 million shares sold short, making up approximately 1.79% of all available shares for trading. With the current trading volume,...

Continue Reading
Exploring the Future of the Phosphate Market: Growth and Trends

Updated Category News Views 520

The Rising Phosphate Market: An Overview The phosphate market is experiencing remarkable growth, projected to soar to approximately $219.74 billion in the coming years, driven by an annual growth rate of 3.9%. This growth is closely linked to the rising global demand for agricultural fertilizers, which play a crucial role in providing essential nutrients for plants....

Continue Reading
Clene Inc. to Engage with Investors at Benchmark Conference

Updated Category News Views 108

Clene Inc. to Engage with Investors at Benchmark Conference Clene Inc. (Nasdaq: CLNN), a dynamic clinical-stage biopharmaceutical company, is making its mark in the healthcare industry by focusing on innovative solutions for neurodegenerative diseases. Their mission is clear: to enhance mitochondrial health and safeguard neuronal functions. With a commitment to tackling...

Continue Reading